offline
AbbVie shares rises on strong Q2, though cosmetic Botox sales tumbled 43%
...
The company had a loss of $739 million, or 46 cents per share, in the second quarter of 2020. It had reported a gain of $807 million, or 49 cents a share, in the same quarter in 2019. Adjusted earnings per share were $2.34, ahead of the FactSet consensus of $2.20. Sales increased to $10.4 billion in the quarter compared with $8.2 billion in the period a year ago. The FactSet consensus for revenue for the quarter was $9.9 billion.
...
https://www.marketwatch.com/story/abbvie...latestnews
![[Bild: ABBVc1dl0829.png]](https://finviz.com/publish/073120/ABBVc1dl0829.png)
...
The company had a loss of $739 million, or 46 cents per share, in the second quarter of 2020. It had reported a gain of $807 million, or 49 cents a share, in the same quarter in 2019. Adjusted earnings per share were $2.34, ahead of the FactSet consensus of $2.20. Sales increased to $10.4 billion in the quarter compared with $8.2 billion in the period a year ago. The FactSet consensus for revenue for the quarter was $9.9 billion.
...
https://www.marketwatch.com/story/abbvie...latestnews
__________________
